Premium
Obstacles to the successful development of an efficacious T cell‐inducing HIV‐1 vaccine
Author(s) -
Haut Larissa Herkenhoff,
Ertl Hildegund C. J.
Publication year - 2009
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0209094
Subject(s) - hiv vaccine , immunology , pandemic , aids vaccines , clinical trial , human immunodeficiency virus (hiv) , biology , vaccine efficacy , virology , immune system , vaccine trial , covid-19 , medicine , disease , bioinformatics , infectious disease (medical specialty)
Preclinical and clinical HIV‐1 cell vaccine development continues to be hampered by the lack of validated preclinical animal models: a discussion about way forward.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom